Showing results (181-190 of 247) with videos related to

Sort By:
Pageof 25
Circulation|October 23, 1997
Normalization of acquired QT prolongation in humans by intravenous potassiumA M Choy, C C Lang, D M Chomsky, et al.
Pacing and Clinical Electrophysiology : PACE|September 1, 1991
Intravenous 3-methoxy-O-desmethyl-encainide in reentrant supraventricular tachycardia: a randomized double-blind placebo-controlled trial in patients undergoing EP studyD L Ware, J T Lee, K T Murray, et al.
British Heart Journal|July 1, 1994
Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methodsA M Choy, D Darbar, C C Lang, et al.
Clinical Pharmacology and Therapeutics|May 1, 1991
Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibersJ Turgeon, C Funck-Brentano, H T Gray, et al.
American Heart Journal|July 1, 1980
Tocainide therapy for refractory ventricular arrhythmiasD M Roden, D M Roden, S B Reele, et al.
American Heart Journal|October 20, 1998
Abnormalities of the QT interval in primary disorders of autonomic failureA M Choy, C C Lang, D M Roden, et al.
Clinical Pharmacology and Therapeutics|January 3, 2013
Inclusion of pediatric samples in an opt-out biorepository linking DNA to de-identified medical records: pediatric BioVUT L McGregor, S L Van Driest, K B Brothers, et al.
Circulation|May 1, 1989
Stereoselective disposition and pharmacologic activity of propafenone enantiomersH K Kroemer, C Funck-Brentano, D J Silberstein, et al.
The American Journal of Cardiology|May 1, 1986
Concentration-dependent pharmacologic properties of sotalolT Wang, R H Bergstrand, K A Thompson, et al.
Circulation|April 1, 1987
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequencesL A Siddoway, K A Thompson, C B McAllister, et al.
Pageof 25